Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ALLERGAN INC.

Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.

Allergan Inc. is part of Business Exchange, suggested by Ulli Muenker. This topic contains 211 news and 83 blog items. Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from like-minded professionals.

News

Recent news on this topic.

UPDATE 1-Spectrum inks deal with Korea's Handok for cancer drugmore

T: Quote, Profile, Research) to develop and market apaziquone in Asia. It also has a collaboration agreement with...

Spectrum Pharmaceuticals and Handok Pharmaceuticals Announce Collabora...more

of nonmuscle invasive bladder cancer by intravesical instillation. Spectrum Pharmaceuticals has previously entered into...

FACTBOX-Winners, losers in U.S. Senate health billmore

and it could reduce demand for their services. That in turn could cut sales for companies such as Allergan Inc and...

FACTBOX: Winners, losers in Senate health billmore

and it could reduce demand for their services. That in turn could cut sales for companies such as Allergan Inc and...

Senate nears first healthcare votemore

were expected, but a surprise proposal for a 5 percent tax on cosmetic treatments hurt companies such as Allergan Inc...

US Cosmetic Medical Market Faces New Challenge In Senate Billmore

downturn. The news modestly blemished stocks Thursday of companies that make cosmetic products, including Botox and...

The Botax? Nip/tuck levy to help health care planmore

on an easy target that is only punitive and not corrective,' said Caroline Van Hove, a spokeswoman for Allergan Inc.

Biotech Stocks: Senate bill weighs on Allergan, Medicismore

biggest gaining and declining stocks (Nov. 18) Story Quotes Comments Screener (3) Alert Email Print BOSTON...

WRAPUP 2-U.S. Senate eyes first healthcare votemore

i numPages) else addImpression('1390430_Share Links Share: addImpression('460349_Next Article Next Article: #alsoOn...

UPDATE 1-Healthcare stocks not unduly hurt by Senate planmore

expected, but a surprise proposal for a 5 percent tax on cosmetic treatments is hurting companies such as Allergan Inc...

Live Webcast on Financial Reporting in Multiple Jurisdictions: What Sh...more

Partner, Assurance Services, Professional Practice - Accounting, Ernst & Young, LLP. Terilea J. Wielenga, Vice...

Healthcare stocks not unduly hurt by Senate planmore

expected, but a surprise proposal for a 5 percent tax on cosmetic treatments is hurting companies such as Allergan Inc...

Senate bill weighs on Allergan, Medicismore

s biggest gaining and declining stocks (Nov. 18) Story Quotes Comments Screener (2) AlertEmail Print BOSTON...

FACTBOX-Winners, losers in U.S. Senate health billmore

and it could reduce demand for their services. That in turn could cut sales for companies such as Allergan Inc (AGN.

Allergan, Medicis fall on health plan proposalmore

expected, but a surprise proposal for a 5 percent tax on cosmetic treatments could hurt companies such as Allergan Inc...

Research and Markets: Ophthalmic Pharmaceutical Drugs - A Global Marke...more

14. REST OF WORLD EXHIBITS COMPANIES PROFILED * Akorn, Inc (USA) * Alcon Eye Care, Inc (USA) * Allergan, Inc.

Lightning Round OT: Apache, Brocade, Allergan and Moremore

the Mad Money website? write("");© 2009 CNBC, Inc. All Rights ReservedTopics:Stock Picks | Stock...

Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update...more

period of 2008, a $0.5 million, or 8.3% decrease, mainly due to sharing by its partner, Allergan Inc., of apaziquone...

UPDATE 1-Spectrum, Nippon Kayaku sign cancer drug deal in Asiamore

two latestage clinical trials as a treatment for nonmuscle invasive bladder cancer. Spectrum has a collaboration...

Sun Pharma gets U.S. nod for generic Acularmore

generic Acular, used in treatment of ocular itching. The drug is the therapeutic equivalent of Acular Ophthalmic...

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opt...more

day following patent expiration. This strength of ketorolac is therapeutically equivalent to Acular® Ophthalmic...

Some New Big-Cap Leaders Lag In IBD Ratingsmore

By JUAN CARLOS ARANCIBIA, INVESTOR'S BUSINESS DAILYPosted 07:04 PM ET Featured Stocks Adobe Systems Inc Allergan Inc CL...

Phase Forward Reports Third Quarter 2009 Results Non-GAAP revenues of ...more

5 million at the end of the third quarter of 2008. Third Quarter and Recent Business Highlights -- Allergan, Inc.

WRAPUP 2-Avon sales miss on weak North America, Arden beatsmore

to firm up over time.' Arden also sells Prevage anti-aging cream, which it created in alliance with Botox-maker...

UPDATE: Allergan 3Q Profit Rises 8.3% With Botox Helpmore

with details on results, recent Botox filings, CEO and analyst comments, updated share price.) Of DOW JONES NEWSWIRES...

Top Sources: Allergan Inc.

  • grinza.com
  • Reuters
  • TheDeal.com
  • MarketWatch
  • ocbj.com
  • ABC News
  • CNN Money
  • Los Angeles Times
  • online.wsj.com
  • modernmedicine.com

Most Active Users in this Topic

see all contributors...

Featured White Papers

Post a Job

Jobs in this Topic

Senior Research Manager - Biomaterials Allergan | Santa Barbara, CA
Posted: Nov 12
Sr Product Support Rep Allergan | California
Posted: Nov 11
Sr. Administrator, EHS Allergan | Santa Barbara, CA
Posted: Sep 30
Sr. Clinical Research Project Manager Allergan | Santa Barbara, CA
Posted: Nov 17
Product Support Rep Allergan | California
Posted: Nov 11

Report comment contains invalid characters. ()
cancel
Search Cancel